Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 11 - 04 save search
Harbor Custom Development, Inc. Authorizes New Stock Repurchase Program
Published: 2021-11-04 (Crawled : 13:00) - globenewswire.com
HCDI | $0.199 -24.47% 1.2M
|
Finance
|
| O: 12.5%
H: 46.38%
C: 6.76%
program
Review by Journal of Neuroscience Shows No Evidence of Data Manipulation in Technical Paper Foundational to Cassava Sciences’ Lead Drug Candidate
Published: 2021-11-04 (Crawled : 14:00) - globenewswire.com
SAVA | $19.61 -7.46% -8.06% 1.3M
|
Health Technology
|
| O: 21.78%
H: 44.93%
C: 22.32%
drug
Providence Film Group, A Valiant Eagle, Inc. Subsidiary (OTC:PSRU) Enters Into Landmark Film Development Agreement with New Republic Pictures and Renowned American Film Producer, Brian Oliver
Published: 2021-11-04 (Crawled : 16:00) - prnewswire.com
PSRU | $0.0001 0.0% 7.7M
|
Manufacturing
|
| O: 0.0%
H: 17.5%
C: -2.5%
liver
iAnthus Provides Corporate Update and Notice of Florida Regulatory Approval for Recapitalization Transaction Change of Ownership
Published: 2021-11-04 (Crawled : 21:00) - prnewswire.com
ITHUF | $0.0176 -10.56% 7.1K
|
Process Industries
|
| O: -0.66%
H: 14.39%
C: -2.56%
approval
Dogness Completes Over $1 Million in Pet-Tech Shipments to a Major U.S. Retailer to Meet Increased Holiday Demand
Published: 2021-11-04 (Crawled : 13:00) - prnewswire.com
DOGZ | $6.63 -1.19% -1.21% 20K
|
Consumer Non-Durables
|
| O: -2.34%
H: 14.11%
C: 8.13%
ema
VectivBio to Present at the Credit Suisse 30th Annual Healthcare Conference
Published: 2021-11-04 (Crawled : 13:00) - biospace.com/
VECT | $16.85 0.12% 130K
|
Professional, Scientific, and T...
|
| O: -4.12%
H: 13.96%
C: 5.74%
conference
NN, Inc. Reports Financial Results For Third Quarter 2021
Published: 2021-11-04 (Crawled : 21:00) - prnewswire.com
NNBR | $3.86 -1.03% -1.04% 210K
|
Producer Manufacturing
|
| O: -4.75%
H: 13.7%
C: 9.21%
financial results results
Research Frontiers Reports Third Quarter 2021 Financial Results
Published: 2021-11-04 (Crawled : 20:00) - smartglass.com
REFR | $1.56 -1.89% -1.92% 49K
|
Electronic Technology
|
| O: 1.15%
H: 12.73%
C: 12.27%
financial results results research
Karyopharm Announces New Interim Phase 2 Selinexor Data in Myelofibrosis Selected for Oral Presentation at the American Society of Hematology 2021 Annual Meeting and Exposition
Published: 2021-11-04 (Crawled : 15:00) - biospace.com/
KPTI | $1.16 -9.38% -10.34% 1.4M
|
Health Technology
|
| O: -5.79%
H: 12.57%
C: 6.55%
presentation ema phase 2 fibrosis
Cybin Granted DEA Schedule I Manufacturing License
Published: 2021-11-04 (Crawled : 12:15) - biospace.com/
CYBN | $0.3677 -0.6% 0.35% 1.8M
|
n/a
|
| O: 0.53%
H: 12.11%
C: 11.05%
license granted grant
Primo Water Corporation Announces Third Quarter 2021 Results and Planned Exit of its North American Single-Use Retail Bottled Water Business
Published: 2021-11-04 (Crawled : 11:00) - prnewswire.com
PRMW | $18.43 1.71% 0.0% 800K
|
Consumer Non-Durables
|
| O: 3.6%
H: 11.37%
C: 11.31%
PRMW | $18.43 1.71% 0.38% 800K
|
Consumer Non-Durables
|
| O: 3.6%
H: 11.37%
C: 11.31%
results
United States Bottled Water Market Report 2021-2025: Data and Analysis putting the U.S. Market in Context of the Global Perspective
Published: 2021-11-04 (Crawled : 14:00) - prnewswire.com
PRMW | $18.43 1.71% 0.0% 800K
|
Consumer Non-Durables
|
| O: 3.6%
H: 11.37%
C: 11.31%
PRMW | $18.43 1.71% 0.38% 800K
|
Consumer Non-Durables
|
| O: 3.6%
H: 11.37%
C: 11.31%
PEP | $174.1 1.06% 1.05% 6.6M
|
Consumer Non-Durables
|
| O: -0.05%
H: 0.21%
C: 0.05%
The Relaunch of the Product Launch.
Published: 2021-11-04 (Crawled : 14:00) - qumu.com
QUMU | $0.8988 0.71% 1.1% 0
|
Electronic Technology
|
| O: 2.44%
H: 10.95%
C: 6.19%
The No Town Hall Town Hall.
Published: 2021-11-04 (Crawled : 14:00) - qumu.com
QUMU | $0.8988 0.71% 1.1% 0
|
Electronic Technology
|
| O: 2.44%
H: 10.95%
C: 6.19%
IGM Biosciences Announces Third Quarter 2021 Financial Results and Provides Corporate Update
Published: 2021-11-04 (Crawled : 14:00) - igmbio.com
IGMS | $7.2 -2.83% -2.92% 220K
|
Health Technology
|
| O: -9.65%
H: 10.43%
C: 8.35%
financial results results bioscience
Abstract #132: A Phase 1 Dose Escalation Study of IGM-2323, a Novel Anti-CD20 x Anti-CD3 IgM T Cell Engager (TCE) in Patients with Advanced B-Cell Malignancies
Published: 2021-11-04 (Crawled : 14:00) - igmbio.com
IGMS | $7.2 -2.83% -2.92% 220K
|
Health Technology
|
| O: -9.65%
H: 10.43%
C: 8.35%
anti-cd3 phase 1 t-cell
Birinapant clinical study initiated by IGM Biosciences
Published: 2021-11-04 (Crawled : 14:15) - prnewswire.com
IGMS | $7.2 -2.83% -2.92% 220K
|
Health Technology
|
| O: -9.65%
H: 10.43%
C: 8.35%
initiated bioscience
Multimeric IgM Antibodies Targeting DR5 are Potent and Rapid Inducers of Tumor Cell Apoptosis In Vitro and In Vivo
Published: 2021-11-04 (Crawled : 17:00) - igmbio.com
IGMS | $7.2 -2.83% -2.92% 220K
|
Health Technology
|
| O: -9.65%
H: 10.43%
C: 8.35%
antibody in vitro
Tuesday Morning Corporation Announces First Quarter Fiscal 2022 Results
Published: 2021-11-04 (Crawled : 11:00) - globenewswire.com
TUEM | $0.5298 0
|
Retail Trade
|
| O: -6.64%
H: 10.22%
C: 4.44%
results
CleanSpark Announces Monthly Bitcoin Mining Data Updates to Increase Industry Transparency, Shares First Report
Published: 2021-11-04 (Crawled : 13:00) - globenewswire.com
CLSK | $17.2 5.98% 5.64% 45M
|
Miscellaneous
|
| O: -2.09%
H: 9.61%
C: 2.04%
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.